Internal Medicine · Dearborn, MI
NPI
1104895697
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5280 Oakman Blvd
Dearborn, MI, 48126
Phone (313) 846-1997
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
1,925 services
Medicare patients, 2024
191
Average age 70
Drug cost, 2024
$1.8M
17,180 prescriptions
Company payments, 2025
$2,618
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sami K Abufarha was code 99214 (office e&m - established), 518 times for 171 patients. In total Sami K Abufarha billed 1,925 services in 58 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 518 | 171 | $84.92 | $44K |
| 99213 Office E&M - Established | Office | 383 | 134 | $56.64 | $22K |
| 96372 Injection Administration | Office | 146 | 48 | $10.61 | $1,549 |
| 36415 Venipuncture Blood Collection | Office | 138 | 96 | $8.65 | $1,194 |
| 96127 Behavioral Health Services | Office | 84 | 61 | $3.52 | $296 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 60 | 38 | $25.35 | $1,521 |
| 87804 Immunoassay | Office | 58 | 27 | $16.22 | $941 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 50 | 26 | $0.09 | $4.47 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 49 | 49 | $129.16 | $6,329 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 42 | 42 | $18.59 | $781 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 36 | 23 | $216.12 | $7,780 |
| 87811 Immunoassay | Office | 35 | 31 | $40.55 | $1,419 |
| 83036 Blood Count | Office | 29 | 29 | $9.52 | $276 |
| 93000 Electrocardiogram | Office | 28 | 26 | $9.44 | $264 |
| 81002 Clinical Chemistry | Office | 27 | 23 | $3.41 | $92.07 |
By year: 2022 $161K for 2,735 services; 2023 $126K for 2,404 services; 2024 $98K for 1,925 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 138 | 96 | $8.65 | $1,194 |
| 87804 Immunoassay | 58 | 27 | $16.22 | $941 |
| 87811 Immunoassay | 35 | 31 | $40.55 | $1,419 |
| 83036 Blood Count | 29 | 29 | $9.52 | $276 |
| 81002 Clinical Chemistry | 27 | 23 | $3.41 | $92.07 |
Medicare prescription drug claims, 2024
In 2024, the drug Sami K Abufarha prescribed most often to Medicare patients was Atorvastatin Calcium, with 978 prescriptions and refills. In total Sami K Abufarha wrote 17,180 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 978 | 1,420 | 195 | $5,264 |
| Omeprazole Generic | 779 | 974 | 149 | $3,333 |
| Diclofenac Sodium Generic | 637 | 667 | 138 | $14K |
| Amlodipine Besylate Generic | 491 | 704 | 97 | $1,528 |
| Losartan Potassium Generic | 466 | 643 | 93 | $2,582 |
| Metformin Hcl Generic | 448 | 627 | 91 | $1,953 |
| Tamsulosin Hcl Generic | 419 | 567 | 82 | $3,001 |
| Ibuprofen Generic | 370 | 383 | 110 | $3,132 |
| Metoprolol Succinate Generic | 346 | 524 | 76 | $3,323 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 331 | 408 | 84 | $14K |
| Furosemide Generic | 300 | 356 | 63 | $678 |
| Fluticasone Propionate Generic | 287 | 355 | 88 | $3,240 |
| Levothyroxine Sodium Generic | 282 | 390 | 55 | $2,207 |
| Famotidine Generic | 254 | 316 | 59 | $2,960 |
| Jardiance Empagliflozin | 228 | 260 | 48 | $150K |
Brand drugs: 2,888 claims; generic drugs: 13,804 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sami K Abufarha $2,618 ($2,618 in general payments such as food, travel and fees) from 25 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $314.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 10 | $314 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $313 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $263 |
| Abbvie Inc. ABBV | 6 | $225 |
| Amgen Inc. AMGN | 4 | $181 |
| Astellas Pharma US Inc 4503.T | 4 | $170 |
| GlaxoSmithKline, LLC. GSK | 3 | $156 |
| Lilly USA, LLC LLY | 10 | $144 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $99.08 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $99.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.